Clinical trials: Iron-Deficiency
Anemia, Iron Deficiencies
Long-term Outcomes Sub-Study of Preoperative Combined Iron Therapy
This is a sub-study of the Preoperative Combined Iron Therapy trail in which some participants will be additionally randomized to combined iron supplementation or standarded treatment control to evaluate the impact on long-term…
- Conditions
- Anemia, Iron Deficiencies, Cardiac Surgery
- Trial name
- NCT06968936
- Testing
- Sucrose Iron，subcutaneous recombinant human erythropoietin，intravenous vitamin C, Routine perioperative management
- Where
- China
- Volunteers
- 400 people
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
Iron Deficiency Anemia, Inflammation
Anemia and Inflammation
During inflammation hepcidin concentrations are increased, leading to a decrease in iron absorption. In iron deficiency anemia hepcidin is suppressed due to the activation of erythropoiesis.
- Trial name
- NCT03618914
- Testing
- Dultavax and Vaxigrip
- Where
- Morocco
- Volunteers
- 50 people, healthy volunteers welcome
- Sponsor
- Swiss Federal Institute of Technology
Iron Deficiency Anemia
Efficacy and Safety Study of Iron Sucrose and Oral Iron Acetyl-transferrin Hydroglycerin
multi-center, prospective, randomized, open-labeled, active-drug-controlled, two-parallel-group-comparison(venoferrun group vs Bolgre group)study
- Trial name
- NCT00802139
- Testing
- venoferrum(iron sucrose), Bolgre (Iron acetyl-transferase)
- Where
- 3 sites in South Korea
- Volunteers
- 58 people
- Sponsor
- JW Pharmaceutical
Iron Deficiency, Malabsorption
Malabsorption as a Cause of Iron Treatment Failure in Infants
Infants should receive prophylacatic iron supplementation since age 4 months till one year. Patients suffering from malabsorption, mainly Giardia infestation may develop iron deficiency resistent to further iron treatment.
- Trial name
- NCT00456729
- Testing
- Metronidazole, Blood tests
- Where
- Israel
- Volunteers
- 100 people
- Sponsor
- HaEmek Medical Center, Israel
Heart Failure, Iron-deficiency
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study
The primary objective of this study is to determine the efficacy and safety of iron therapy using intravenous (IV) ferric carboxymaltose (FCM), relative to placebo in the treatment of participants in heart failure with a reduced…
- Trial name
- HEART-FID (NCT03037931)
- Testing
- Ferric Carboxymaltose
- Where
- 345 sites in United States, Australia and 11 more
- Volunteers
- 3,065 people
- Sponsor
- American Regent, Inc.
Chronic Heart Failure
Iron Stores and Skeletal Muscle Metabolism in Chronic Heart Failure
Iron deficiency may contribute to exercise intolerance by altering mitochondrial oxidative capacity in skeletal muscle. Functional iron deficiency is common in heart failure patients, but the relationship to exercise intolerance…
- Trial name
- NCT02737995
- Testing
- Ferric carboxymaltose infusion
- Volunteers
- 8 people
- Sponsor
- NYU Langone Health
Iron-deficiency, Pregnancy Anemia
Feasibility or Oral Lactoferrin to Prevent Iron Deficiency Anemia in Obese Pregnancy
Maternal iron deficiency anemia is associated with maternal and infant mortality, spontaneous preterm birth, maternal postpartum hemorrhage, and neurocognitive defects in the neonate.
- Conditions
- Iron-deficiency, Pregnancy Anemia, Obesity
- Trial name
- NCT04810546
- Testing
- Jarrow Formulas Oral Bovine Lactoferrin Supplement
- Where
- United States
- Volunteers
- 23 people, healthy volunteers welcome
- Sponsor
- University of Illinois Chicago
Heart Failure, Iron Deficiency
The Effects of Low-Dose Versus High-Dose Intravenous IRON Therapy With Ferric DerisomaltOSE in Patients With Chronic Heart Failure and Iron Deficiency
This study will address whether intravenous (IV) iron repletion with a more intensive target will provide greater benefits in improving exercise capacity for patients with chronic heart failure and iron deficiency.
- Trial name
- IRONDOSE (NCT06427343)
- Testing
- High-dose ferric derisomaltose, Low-dose ferric derisomaltose
- Where
- China
- Volunteers
- 114 people
- Sponsor
- China-Japan Friendship Hospital
Hereditary Hemochromatosis
A Study to Evaluate BBI-001 in Hereditary Haemochromatosis (HH) Patients and Iron Deficient Volunteers
This is a first in human, double-blind, randomized, placebo-controlled, two-arm crossover study evaluating the safety, tolerability and PD of ascending dose levels of BBI-001 after: a single administration in iron deficient male…
- Trial name
- NCT05238207
- Testing
- BBI-001, Original Fibre Metamucil
- Where
- Australia
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- Bond Biosciences
Anemia, Iron-deficiency
Association Between Anaemia and Handgrip Strength in Female Planned for Major Surgery and the Effect of Intravenous Iron on Handgrip Strength
This is a sub-study parallel to ProPBM : A Randomised Control Trial Comparing a Modified Patient Blood Management Protocol Against Standard Care for Patients Undergoing Major Surgery (NCT03888768).
- Conditions
- Anemia, Iron-deficiency, Patient Blood Management, Iron Deficiency Anemia
- Trial name
- NCT04642521
- Testing
- Jamar hydraulic hand dynamometer
- Where
- Malaysia
- Volunteers
- 65 people, healthy volunteers welcome
- Sponsor
- University of Malaya
Anemia, Iron Deficiency, Anemia
Potential Harms of Untargeted Iron Supplementation in Cambodia Where Iron Deficiency is Not the Cause of Anemia
In 2016, the World Health Organization (WHO) set a global policy recommending daily oral iron supplementation (60 mg iron) for 12 weeks for all women living in countries where anemia prevalence is >40%, such as in Cambodia.
- Conditions
- Anemia, Iron Deficiency, Anemia, Intestinal Inflammation, Inflammation
- Trial name
- NCT04017598
- Testing
- Ferrous sulfate, Ferrous Bisglycinate
- Where
- Cambodia
- Volunteers
- 480 people, healthy volunteers welcome
- Sponsor
- University of British Columbia
Iron Deficiency, Restless Leg Syndrome
Probiotics in the Treatment of Iron Deficiency in Children With Restless Leg Syndrome
A double-blind randomized controlled trial comparing iron plus vitamin C plus probiotic (lactobacillus plantarum 299) to iron plus vitamin C plus placebo in correcting the iron deficiency in children with Restless leg syndrome…
- Trial name
- NCT01617044
- Testing
- Probiotics
- Where
- United States
- Volunteers
- 61 people
- Sponsor
- Children's Hospitals and Clinics of Minnesota
Iron Deficiency, Anaemia
Iron & Alginate Study
Iron deficiency anaemia affects around two billion people worldwide. Food fortification with iron is a realistic way to combat this problem.
- Trial name
- NCT01528644
- Testing
- alginate beads containing ferrous gluconate, ferrous gluconate in a capsule, ferrous gluconate in a capsule in presence of calcium
- Where
- United Kingdom
- Volunteers
- 16 people, healthy volunteers welcome
- Sponsor
- University of East Anglia
Anemia, Iron-Deficiency, Puerperal Disorders
Controlled Randomised Trial of Ferric Carboxymaltose and Oral Iron to Treat Postpartum Anemia
200 patients with post partum anemia will be randomised to receive either intravenous iron (intervention group) or peroral iron (control group).
- Conditions
- Anemia, Iron-Deficiency, Puerperal Disorders, Depression, Postpartum
- Trial name
- NCT00929409
- Testing
- Ferric carboxymaltose, Ferrous sulfate tablets
- Where
- 3 sites in Norway
- Volunteers
- 30 people
- Sponsor
- Norwegian University of Science and Technology
Iron Deficiency
Strategies to Reduce Iron Deficiency
The prevalence of iron deficiency in blood donors has been demonstrated to be a direct consequence of repeat blood donations. Given the adverse effects of iron deficiency, it is priority to implement programs to remediate iron…
- Trial name
- STRIDE (NCT02245321)
- Testing
- Ferrous gluconate- 19 mg, Ferrous gluconate- 38 mg, Letter Group- Information Provided
- Where
- 4 sites in United States
- Volunteers
- 702 people, healthy volunteers welcome
- Sponsor
- Westat
Restless Legs Syndrome (RLS)
Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia
Treatment Phase I and II Primary Objective: To evaluate the efficacy and safety of FCM (750 mg dose x 2) for treatment of Restless Legs Syndrome (RLS) in patients with iron-deficiency anemia (IDA).
- Trial name
- NCT02826681
- Testing
- Injectafer® (Ferric Carboxymaltose - FCM)
- Where
- 8 sites in United States
- Volunteers
- 70 people
- Sponsor
- American Regent, Inc.
Iron Deficiency Anaemia in Childbirth
Ferric Derisomaltose (Iron Isomaltoside) Versus Iron Sucrose for Treatment of Iron Deficiency in Pregnancy
Ion deficiency anemia (IDA) is associated with poor neonatal outcomes and maternal morbidity. Iron replacement may be done with oral iron or intravenous iron, with intravenous iron being utilized later in pregnancy or if there is…
- Trial name
- NCT05251493
- Testing
- Iron Isomaltoside 1000, ferric derisomaltose, Iron sucrose
- Where
- Canada
- Volunteers
- 280 people, healthy volunteers welcome
- Sponsor
- Saskatchewan Health Authority - Regina Area
Heart Failure With Normal Ejection Fraction, Ferropenic Anemia
Effects of Iron Therapy in Heart Failure With Preserved Ejection Fraction and Iron Deficiency (PREFER-HF)
The purpose of the study is to evaluate whether the administration of iron to patients with heart failure and preserved ejection fraction results in an improvement of symptoms and functional class, in addition to evaluating…
- Trial name
- PREFER-HF (NCT03833336)
- Testing
- Ferric carboxymaltose, Ferroglycine Sulfate, Sucrosomial Iron
- Where
- 2 sites in Spain
- Volunteers
- 72 people
- Sponsor
- Institut de Recerca Biomèdica de Lleida
Iron Deficiency, Chronic Heart Failure
A Study to Compare the Use of Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron Deficiency
The purpose of this study is to determine, relative to placebo, the effect of iron repletion therapy using intravenous (IV) ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency.
- Trial name
- CONFIRM-HF (NCT01453608)
- Testing
- Ferinject (ferric carboxymaltose)
- Where
- 2 sites in Poland, Russia
- Volunteers
- 304 people
- Sponsor
- Vifor Pharma
Postural Orthostatic Tachycardia Syndrome
Iron Sucrose in Adolescents With Iron Deficiency and Postural Orthostatic Tachycardia Syndrome (POTS)
This study is designed to investigate whether the treatment of non-anemic iron deficiency with intervenous iron sucrose will result in decreased symptom reporting and improved cardiovascular indices in adolescents (age 12-21)…
- Trial name
- NCT01978535
- Testing
- Iron infusion, Normal saline infusion
- Where
- United States
- Volunteers
- 3 people
- Sponsor
- Mayo Clinic